SCHONFELD STRATEGIC ADVISORS LLC – Halozyme Therapeutics, Inc. Transaction History
SCHONFELD STRATEGIC ADVISORS LLC portfolio value:
$15.39M
portfolio value
SCHONFELD STRATEGIC ADVISORS LLC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +32.55% | 95.59K shares | 2.47M | $39.54 | 389.23K |
| Q2 2022 | share | Increase | +45.51% | 91.83K shares | 4.87M | $44 | 293.63K |
| Q1 2022 | share | Increase | +8.63% | 16.03K shares | 579K | $39.88 | 201.80K |
| Q4 2021 | share | Increase | +32.69% | 45.76K shares | 1.77M | $40.32 | 185.76K |
| Q3 2021 | share | Decrease | -43.00% | -105.6K shares | -5.45M | $40.68 | 140K |
| Q2 2021 | share | Increase | +41.64% | 72.19K shares | 3.92M | $45.41 | 245.6K |
| Q1 2021 | share | Increase | +315.45% | 131.66K shares | 5.44M | $41.69 | 173.40K |
| Q4 2020 | share | Decrease | -41.95% | -30.16K shares | -108K | $42.71 | 41.73K |
| Q3 2020 | share | Increase | +19.06% | 11.50K shares | 271K | $26.28 | 71.9K |
| Q2 2020 | share | Increase | +117.98% | 32.68K shares | 1.12M | $26.81 | 60.39K |
| Q1 2020 | share | Increase | 0.00% | 27.70K shares | 498K | $17.99 | 27.70K |
| Q3 2019 | share | Decrease | -100.00% | -57.2K shares | -983K | $15.51 | 0 |
| Q2 2019 | share | Decrease | -67.61% | -119.37K shares | -1.86M | $17.18 | 57.2K |
| Q1 2019 | share | Increase | +667.72% | 153.57K shares | 2.50M | $16.1 | 176.57K |
| Q4 2018 | share | Increase | 0.00% | 23K shares | 336K | $14.63 | 23K |
| Q1 2017 | share | Decrease | -100.00% | -70.42K shares | -696K | $12.96 | 0 |
| Q4 2016 | share | Increase | 0.00% | 70.42K shares | 696K | $9.88 | 70.42K |